About NuPulseCV
NuPulseCV is a Healthcare company based in Raleigh (United States) founded in 2011 by Douglas H Altschuler. Implantable mechanical pump is developed for congestive heart failure treatment. NuPulseCV has raised $14.18 million across 6 funding rounds from investors including HHS. The company has 16 employees. Its chief executive, as recorded, is Douglas H Altschuler. NuPulseCV offers products and services including NuPulse Voyage, Voyage Blood Pump, NuPulse Drive Unit, and External Real-Time EKG Patch. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is NUPULSECV, INC. Its competitors include CVRx, Adona Medical and Element Science; 3 of its 3 listed competitors have raised funding.
Company details
NuPulseCV was founded in 2011 in Raleigh, United States, within the cardiovascular medical device sector. A minimally invasive implantable pump is being developed to assist patients with advanced heart failure. The first-in-human trial received FDA approval in late 2015, and initial implants were successfully conducted at the University of Chicago Medicine on six patients. The system is designed for bridge-to-transplant, bridge-to-recovery, and long-term destination therapy applications.
- Headquarters Raleigh, United States
- Employees 16
- Founders Douglas H Altschuler
- SectorsHealthcare
- Email••••••••
- Website nupulsecv.com
- Social LinkedIn Facebook
- Legal Name Nupulsecv, Inc.
- Total Equity Funding$14.18M (USD)
in 6 rounds
- Latest Funding Round$256.57K (USD), Grant
Jul 2021
- Investors
- Employee Count16
Products & Services of NuPulseCV
NuPulseCV offers a comprehensive portfolio of products and services, including NuPulse Voyage, Voyage Blood Pump, NuPulse Drive Unit, and External Real-Time EKG Patch.
Minimally invasive pump for chronic heart failure support
Device placed in aorta to aid blood flow
Lightweight unit for unrestricted patient movement
Patented patch for real-time heart monitoring
Funding Insights of NuPulseCV
NuPulseCV has successfully raised a total of $14.18M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $256.57 thousand completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.18M
- Total Rounds 6
- Last Round Grant — $256,574
- First Round $6.7M
(Aug 2014)
- Investors Count 1
All 6 funding rounds of NuPulseCV with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in NuPulseCV
NuPulseCV has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for NuPulseCV
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NuPulseCV
8 people are tracked at NuPulseCV (3 in leadership, 5 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Douglas H Altschuler | Founder & CEO | Leadership |
Robert Hall | Director Research, Development And Quality | Leadership |
Ryan McCormick | Vice President Of Operations And Development | Leadership |
Madiha Jamal | Sr. Design Assurance Engineer/ Project Engineer | Team |
Japen Mehta | Research And Development Engineer | Team |
Peter Mangum | Senior Software Architect | Team |
Digvijay Patil | Mechanical Design And Development Engineer | Team |
Emma Tyler | Product Development Engineer | Team |
Complete people profiles for NuPulseCV
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NuPulseCV
3 dated milestones of NuPulseCV across 10 years, from founding to its latest funding, stage changes and deals.
- Founded NuPulseCV is founded.
- Funding First funding round of $6.7M.
- Funding Latest funding round, Grant, of $257K.
Competitors of NuPulseCV
NuPulseCV has 3 listed competitors in our database, 3 of them funded. They include CVRx, Adona Medical and Element Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| adonamed.com | 2017 | Campbell, United States | $71M | Medical devices for heart failure management are developed. | ||
| elementscience.com | 2013 | San Francisco, United States | $192.6M | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. |
Detailed competitors of NuPulseCV
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as NuPulseCV (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nupulsecv
Complete news archive for NuPulseCV
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuPulseCV
NuPulseCV was founded in 2011 and raised its 1st funding round 3 years after it was founded.
NuPulseCV is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Douglas H Altschuler is the CEO of NuPulseCV, as recorded in our data. They have also founded this company.
NuPulseCV is a funded company, having raised a total of $14.18M across 6 funding rounds to date. The company's 1st funding round was a Series A of $6.7M, raised on Aug 2014.
NuPulseCV has 16 employees.
NuPulseCV was founded in 2011 in Raleigh, United States, within the cardiovascular medical device sector. A minimally invasive implantable pump is being developed to assist patients with advanced heart failure. The first-in-human trial received FDA approval in late 2015, and initial implants were successfully conducted at the University of Chicago Medicine on six patients. The system is designed for bridge-to-transplant, bridge-to-recovery, and long-term destination therapy applications.
NuPulseCV's top competitors include CVRx, Adona Medical and Element Science.
NuPulseCV offers NuPulse Voyage, Voyage Blood Pump, NuPulse Drive Unit, and External Real-Time EKG Patch.
NuPulseCV has 1 investor. Key investors include HHS.
NuPulseCV operates through Nupulsecv, Inc..